Respiratory Syncytial Virus (RSV) Vaccine

Your participation can help us learn more about preventing severe or acute illness from RSV.
Find out today if the VANIR Study is right for you!

Learn about a new investigational vaccine called MVA-BN-RSV and whether it can protect people from getting seriously ill from Respiratory Syncytial Virus, or RSV. RSV can cause severe or acute respiratory illness in older adults. Compensation may be available to those that qualify. 

  • Are 60 years of age or older
  • Are overall healthy 
  • Are willing and able to use a smartphone or tablet application to record information during the study

You may be able to join the study if you:

*Other criteria will need to be met to confirm your eligibility for this study.

To learn more, fill out the form below. 















Skip to content